Encompass Health Stock News

BIRMINGHAM, Ala., Dec. 9, 2021 /PRNewswire/ -- Encompass Health Corporation ("Encompass Health" or the "Company") (NYSE: EHC), a national leader in integrated healthcare, offering facility-based and home-based patient care through its network of inpatient rehabilitation hospitals and home

Equities analysts predict that Encompass Health Co. (NYSE:EHC) will report earnings of $1.06 per share for the current fiscal quarter, according to Zacks Investment Research. Five analysts have made estimates for Encompass Health’s earnings, with estimates ranging from $1.02 to $1.09. Encompass Health reported earnings per share of $0.93 during the same quarter last year, […]

Nisa Investment Advisors LLC reduced its stake in shares of Encompass Health Co. (NYSE:EHC) by 3.8% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 20,087 shares of the companys stock after selling 783 shares during the period. Nisa Investment Advisors LLCs []

Copeland Capital Management LLC increased its position in Encompass Health Co. (NYSE:EHC) by 7.1% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 672,947 shares of the companys stock after acquiring an additional 44,869 shares during the period. Encompass Health []

Encompass Health Co. (NYSE:EHC) Director Terrance Williams acquired 354 shares of the firms stock in a transaction that occurred on Thursday, December 2nd. The shares were bought at an average price of $56.61 per share, with a total value of $20,039.94. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, []

Encompass Health Co. (NYSE:EHC) Director Terrance Williams acquired 354 shares of Encompass Health stock in a transaction that occurred on Thursday, December 2nd. The stock was acquired at an average price of $56.61 per share, with a total value of $20,039.94. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, []

BIRMINGHAM, Ala. and AMARILLO, Texas, Dec. 3, 2021 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced plans to build a freestanding, 40-bed inpatient rehabilitation hospital in Amarillo, Texas. The hospital will be located north of the Wallace Boulevard and Gentry Drive

Encompass Health Corporation found using ticker (EHC) have now 11 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The range between the high target price and low target price is between 110 and 94 and has a mean target at 101.09. Now with the previous closing price of 61.18 this would imply there is a potential upside of 65.2%. The day 50 moving average is 68.21 and the 200 day moving average is 78.25. The company has a market cap of $6,219m. Find out more information at: /> [stock_market_widget type="chart" symbol="EHC" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

Encompass Health Corp (EHC) shares closed today at 1.6% above its 52 week low of $60.20, giving the company a market cap of $6B. The stock is currently down 25.2% year-to-date, down 24.7% over the past 12 months, and up 52.7% over the past five years. This week, the Dow Jones Industrial Average fell 1.9%, and the S&P 500 fell 2.1%. Trading Activity Trading volume this week was 33.9% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.5. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -101.5% The company's stock price performance over the past 12 months lags the peer average by -101.5% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 144.7% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Shares of Encompass Health Co. (NYSE:EHC) have been assigned a consensus recommendation of Buy from the eleven brokerages that are currently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. []

Parametric Portfolio Associates LLC grew its holdings in Encompass Health Co. (NYSE:EHC) by 12.1% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 253,476 shares of the companys stock after purchasing an additional 27,357 shares during the period. Parametric Portfolio []

Encompass Health Co. (NYSE:EHC) has received an average recommendation of Buy from the twelve research firms that are currently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a hold recommendation, nine have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 []

FDx Advisors Inc. raised its holdings in shares of Encompass Health Co. (NYSE:EHC) by 10.4% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,318 shares of the companys stock after purchasing an additional 407 shares during the period. FDx Advisors Inc.s holdings []

Encompass Health (NYSE:EHC) was downgraded by analysts at TheStreet from a b- rating to a c+ rating in a research note issued on Monday, TheStreetRatingsTable reports. Other research analysts also recently issued research reports about the stock. Truist dropped their target price on shares of Encompass Health from $100.00 to $88.00 and set a buy []

Related Stocks: ADUS , LVOX , FRG , TEN , TRMR , EHC , SMLR , ONTF , AVAH , SUPN , DFPH , PRCH , ODP , IPOF , CMAX ,